Presence Of Patient Experience Data Table In FDA Drug Review Summaries ‘Inconsistent’
RTI Health Solutions researchers assessed US FDA review documents over past two years to gauge use of a tool meant to facilitate agency disclosures about what patient experience information it considered.
